SPRIX Nasal Spray is indicated to treat short-term, moderate to moderately severe pain that requires analgesia at the opioid level. Each single-day nasal spray bottle is designed to administered precisely metered doses of 100 microliters of ketorolac tromethamine per spray and contains sufficient quantity to deliver eight sprays.
SPRIX Nasal Spray is absorbed via the nasal mucosa, reaching peak plasma concentration comparable to that achieved with ketorolac tromethamine intramuscular injection.
Related Articles on Anesthesia and Analgesia:
Desflurane Safer Anesthetic for Patients With Alzheimer’s Than Isoflurane
More Than 80% of Anesthesiologists Have Seen Surgical Catastrophes
Study: Brain Resists Emergence From Anesthesia
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
